ReviewScientific reports2025
In-vitro antifungal potential of myco versus bacteria synthesized ZnO NPs against chickpea and apricot pathogen.
Review in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Remedial applications of biosynthesized metal oxide nanoparticles against pathogenic microorganisms.Discover nano · 2026Review
- Nano-enabled Control of A. flavus and F. proliferatum: inhibition of fungal growth and mycotoxin biosynthesis by zinc oxide nanoparticles.Scientific reports · 2026Article
- Phytofabricated zinc oxide nanoparticles (ZnO-NPs) from a medicinal salt-tolerant Oxystelma esculentum (L.f.) Sm. extract and their multifunctional biological activities.Scientific reports · 2026Article
- Green mycosynthesis of ZnO nanoparticles enhances antifungal defense against Fusarium equiseti through metabolic and gene expression modulation.Discover nano · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Chickpea (Cicer arietinum) and Apricot (Prunus armeniaca) both are economically and nutritionally important, these both faces severe losses due to fungal Infections. For several fungal infections, traditional methods of management rely on chemical fungicideswhich have environmental and health risks. The in-vitro antifungal efficacy of myco-synthesized and bacteria-synthesized zinc oxide (ZnO) nanoparticles against pathogens impacting chickpea and apricot is aimed to be compared in this review article. Evaluated for their antifungal effectiveness against Fusarium oxysporum f. sp. ciceris in chickpea and Alternaria solani, myco-synthesized ZnO NPs generated from Trichoderma harzianum and bacteria-synthesized ZnO NPs were using a poisoned food approach, the study evaluated minimum inhibitory concentration (MIC), minimum fungicidal concentration (MFC), and inhibition zone diameter. At lower concentrations, myco-synthesized ZnO NPs shown better antifungal activity than their bacteria-synthesized counterparts, according to results. Surface changes, size, and concentration of nanoparticles were main determinants of antifungal activity. Emphasizing the need of more study to maximize the synthesis and application in agricultural environments, this review underlines the possibilities of ZnO NPs as sustainable substitutes for chemical fungicides.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.